Gierhart Wanda Marie sold (to issuer) $751K of CNK

Gierhart Wanda Marie (Chief Marketing & Content Ofc) sold (to issuer) 23,456 shares of Cinemark Holdings, Inc. (CNK) at $32.00 ($0.75M total) on 2026-06-09 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gierhart Wanda Marie
Published Jun 9, 2026, 9:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 9, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CNK
Neutral
high confidence
Mentioned
$CNK
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNKNeutralLow
01

Why it matters

The disclosure updates the insider transaction record for CNK, but it does not provide new operating, financial, or regulatory information.

02

Market read

Traders may note the insider sale for positioning/flow context, but it is unlikely to drive a fundamental repricing by itself.

03

What to watch

The filing does not indicate whether the sale is part of compensation/withholding mechanics beyond “sale to issuer,” so the signal content is limited without additional context (e.g., other concurrent insider buys/sells).

Relevance 4/10Novelty 6/10Timing: filed 2026-06-09 (same day disclosure)

Background

The article is an SEC Form 4 insider transaction disclosure for Cinemark Holdings, Inc.

Company-level read

Ticker impact

$CNKNeutralHigh confidence
Context

Cinemark officer sold 23,456 shares (~$750.6K) to the issuer on 2026-06-09 under a pre-arranged 10b5-1 plan.

Expected impact

Low near-term impact; any effect is likely noise unless paired with other catalysts.

Evidence & confidence

Form 4 is a primary disclosure, but the transaction is a sale to the issuer under a 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

Minimal; this is company-specific insider liquidity rather than an industry/regulatory development.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with management’s view that near-term valuation is less attractive than longer-term fundamentals.

Key entities

  • Cinemark Holdings, Inc.

    CNK; officer (Chief Marketing & Content Officer) reported a sale to the issuer under a 10b5-1 plan.

  • Gierhart Wanda Marie

    Chief Marketing & Content Officer; sold 23,456 shares on 2026-06-09.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CNKHigh

Morgan Stanley upgrades Cinemark stock rating on box office outlook

Morgan Stanley upgraded Cinemark (CNK) to Overweight with a $50 price target, citing optimism about 2027 box office growth and the company's strong market position. Cinemark's stock has risen 75.3% year-to-date, trading near its 52-week high. The company reported record Q3 earnings of $1.04 per share on $1.06 billion revenue, exceeding expectations. Other analysts have also raised their price targets following the strong performance.

$CNKHighAI 8/10

StoneX raises Cinemark stock price target on strong quarter

StoneX raised its price target on Cinemark (NYSE:CNK) to $45 from $40, citing strong Q3 results with revenue and adjusted EBITDA exceeding estimates. The firm expects continued growth in 2027, supported by a strong film slate and premium expansion. Cinemark's stock has surged 42% in six months. The company reported record Q3 earnings of $1.04 per share, beating estimates, with revenue reaching $1.06 billion.

$CNKMedAI 8/10

Cinemark stock holds at Neutral as B.Riley keeps $42 target

B.Riley maintained a Neutral rating and $42 price target for Cinemark (CNK) after its Q3 earnings beat estimates. Revenue was $1.059B, EBITDA $268M, driven by Latin America sales. Management is optimistic about future box office growth. Shares are up 65% YTD, trading near a 52-week high. Wells Fargo raised its target to $42, citing international success.

$CNKMed

Cinemark Holdings Inc (CNK) (Q3 2026) Earnings Call Highlights: Record Q3 Revenue

Cinemark Holdings (CNK) reported record Q3 2026 revenue, but faced market share compression due to film mix and capacity constraints. The company expects similar challenges in Q4. Cinemark declined to book Netflix's 'Cliff Booth' on IMAX, citing concerns about the release model. Inflationary pressures and capacity constraints are impacting operations. The company has excess cash and may increase buybacks or dividends. CapEx could rise to invest in new builds and theater enhancements.